Glycoprotein VI antibodies and methods thereof

Details Glycoprotein VI antibodies and methods thereof Glycoprotein VI antibodies and methods thereof

2005-04-26

2009-11-03

Szperka, Michael (Department: 1644)

Drug, bio-affecting and body treating compositions

Immunoglobulin, antiserum, antibody, or antibody fragment,...

Monoclonal antibody or fragment thereof

C424S133100, C424S141100, C424S153100, C530S387300, C530S388100, C530S388220, C530S388700

Reexamination Certificate

active

07611707

ABSTRACT:
The present invention describes antibodies generated against platelet membrane glycoprotein VI-(GPVI), methods of producing the anti-GPVI antibodies, and the use of these antibodies as research and immunotherapeutic agents, in particular, as antithrombotic therapeutic agents.

REFERENCES:
patent: 4208479 (1980-06-01), Zuk et al.
patent: 5859205 (1999-01-01), Adair et al.
patent: 6245527 (2001-06-01), Busfield et al.
patent: 6383779 (2002-05-01), Busfield et al.
patent: 6989144 (2006-01-01), Busfield et al.
patent: 6998469 (2006-02-01), Tandon et al.
patent: 7101549 (2006-09-01), Gill et al.
patent: 7291714 (2007-11-01), Busfield et al.
patent: 2002/0141992 (2002-10-01), Nieswandt
patent: 2004/0001826 (2004-01-01), Gill et al.
patent: 2006/0216291 (2006-09-01), Busfield et al.
patent: 2007/0071744 (2007-03-01), Munch et al.
patent: 2007/0172480 (2007-07-01), Clemeston
patent: 2008/0050380 (2008-02-01), Gill et al.
patent: 1 538 165 (2005-06-01), None
patent: WO 00/68377 (2000-11-01), None
patent: WO 01/00810 (2001-01-01), None
patent: WO 0100810 (2001-01-01), None
patent: WO 02/080968 (2002-10-01), None
patent: WO 03/054020 (2003-07-01), None
patent: WO 03/103662 (2003-12-01), None
patent: WO 2005/007800 (2005-01-01), None
patent: WO 2005/054294 (2005-06-01), None
Janeway et al., Immunobiology, 3rdedition, Garland Press, 1997, pp. 3:7-3:11.
Rudikoff et al., Proc Natl Acad Sci U S A. Mar. 1982;79(6):1979-83.
Schulte et al., J. Biol. Chem., 2001, 276:364-368.
Portolano et al., J Immunol. Feb. 1, 1993;150(3):880-7.
Padlan, E.A., Mol Immunol. Feb. 1994;31(3):169-217.
Gruner, S., et al., Relative antithrombotic effect of soluble GPVI dimer compared with anti-GPVI antibodies in mice, Blood 105(4):1492-9 (2005).
Lecut, C., et al., Identification of residues within human glycoprotein VI involved in the binding to collagen: evidence for the existence of distinct binding sites, J. Biol. Chem. 279(50):52293-9 (2004).
Smethurst, P.A., et al., Identification of the primary collagen-binding surface on human glycoprotein VI by site-directed mutagenesis and by a blocking phage antibody, Blood 103(3):903-11 (2004).
P. Declerck, et al., “Generation of Monoclonal Antibodies against Autologous Proteins in Gene-inactivated Mice”, The Journal of Biological Chemistry, vol. 270, No. 15., pp. 8397-8400 (1995).
K. Kato, et al., “The contribution of glycoprotein VI to stable platelet adhesion and thrombus formation illustrated by targeted gene deletion,” Blood, vo. 102, No. 5, pp. 1701-1707 (2003).
M. Qian et al., “Anti GPVI human antibodies neutralizing collagen-induced platelet aggregation isolated from a combinatorial phage display library”, Human antibodies, vol. 11, No. 3, pp. 97-105 (2002).
J. Davies, et al., “Affinity improvement of single antibody VH domains: residues in all three hypervariable regions affect antigen binding”, Immunotechnology, vol. 2, No. 3, pp. 169-179 (1996).

Affiliated with

Also associated with

Rating

Glycoprotein VI antibodies and methods thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Glycoprotein VI antibodies and methods thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glycoprotein VI antibodies and methods thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4072081